Kory James Wentworth, CFO: Entrada Therapeutics TRDA Sell · Filed 24/11/13

Trade details

Type: Insider sale
Amount: $172,567.26
Shares · price: 8,637 sh · $19.98 a share
Held after: 73,849 sh
Stock: Entrada Therapeutics TRDA
Person: Kory James WentworthCFO
Trade date: 24/11/11
Filed: 24/11/13
Days to filing: 2 days

Sold 10.5% of holdings

Share of holding sold: 10.5%

Entrada Therapeutics trades, last 26 weeks

What else happened in Entrada Therapeutics around then

Filed or reported within 30 days of the trade day · 24/10/12~24/12/11

Kory James Wentworth's recent trades

Kory James WentworthCFO
Sell10b5-1 planEntrada Therapeutics
Sell10b5-1 plan
Entrada Therapeutics
TRDA
$32.4K
2,500 sh
$32.4K
Filed 04/02
Traded 04/01
Kory James WentworthCFO
Planned sale10b5-1 planEntrada Therapeutics
Planned sale10b5-1 plan
Entrada Therapeutics
TRDA
$31.6K
2,500 sh
$31.6K
Filed 04/01
Traded 04/01
Kory James WentworthCFO
Sell10b5-1 planEntrada Therapeutics
Sell10b5-1 plan
Entrada Therapeutics
TRDA
$148.3K
11,388 sh
$148.3K
Filed 03/11
Traded 03/10
Kory James WentworthCFO
Sell10b5-1 planEntrada Therapeutics
Sell10b5-1 plan
Entrada Therapeutics
TRDA
$66.2K
5,089 sh
$66.2K
Filed 03/11
Traded 03/09
Kory James WentworthCFO
Planned sale10b5-1 planEntrada Therapeutics
Planned sale10b5-1 plan
Entrada Therapeutics
TRDA
$207.3K
16,477 sh
$207.3K
Filed 03/09
Traded 03/09